tyrosine has been researched along with Cancer of Prostate in 97 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.03) | 18.7374 |
| 1990's | 18 (18.56) | 18.2507 |
| 2000's | 45 (46.39) | 29.6817 |
| 2010's | 25 (25.77) | 24.3611 |
| 2020's | 8 (8.25) | 2.80 |
| Authors | Studies |
|---|---|
| Alatraktchi, FA; Madsen, JS; Malmendal, A; Nasimi, H; Osther, PJS; Schmedes, AV; Zedan, AH | 1 |
| Chen, W; Ding, J; Ge, H; Hao, H; Ji, M; Jiang, Y; Kuang, W; Li, J; Li, Z; Lu, M; Min, W; Sun, C; Wang, L; Wang, X; Xiao, Y; Yang, P; Ye, X; Yuan, K | 1 |
| Chouhan, S; Earp, HS; Luo, J; Mahajan, NP; Mueller, DM; Sawant, M; Sprung, RW; Terrado, M; Weimholt, C | 1 |
| Cao, Q; Chiu, PK; Liang, Y; Ng, CF; Teoh, JY; Tsui, SK; Wang, L; Wei, Y; Wong, CY; Xiong, Q; Ye, DW; Zhu, Y | 1 |
| Chelvam, V; Dudhe, P; Krishnan, MA; Pandit, A; Sengupta, S; Sharma, R | 1 |
| Bartenstein, P; Cyran, CC; Ilhan, H; Mittlmeier, LM; Rodler, S; Staehler, M; Stief, CG; Todica, A; Unterrainer, M | 1 |
| Bidgood, CL; Davis, RA; Gunter, JH; Kumar, R; Levrier, C; Nelson, CC; Sadowski, MC | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Del Priore, G; Gartrell, BA; Retter, A; Roach, M; Scher, HI; Sokol, GH | 1 |
| Bernatchez, P; Foster, LJ; Joshi, B; Liu, Y; Meng, F; Nabi, IR; Saxena, S; Shankar, J; Wong, TH | 1 |
| Anselmino, N; Chiarella, P; Contin, MD; Cotignola, J; D Accorso, N; Giudice, J; Gueron, G; Jaworski, F; Labanca, E; Lage Vickers, S; Leonardi, D; Manzano, V; Meiss, RP; Montagna, DR; Navone, N; Ortiz, EG; Paez, AV; Ruggiero, R; Strazza, A; Vazquez, E; Woloszynska-Read, A | 1 |
| Dong, J; Jiang, L; Liang, Y; Liu, P; Wang, H; Wang, S | 1 |
| Holst, J | 1 |
| Mitra, A | 1 |
| Haidari, M; Wakame, K; Zhang, W | 1 |
| Choi, WS; He, Y; Joh, Y; Kim, H; Kim, K; Kim, KM; Kwon, DD; Lee, JH; Lee, KY; Lu, Q; Ryu, T; Zheng, M | 1 |
| Ametamey, SM; Chiotellis, A; Krämer, SD; Leutwiler, DS; Mu, L; Müller, A; Schibli, R; Weyermann, K | 1 |
| Chen, Q; Chen, Z; Gao, WQ; Ji, Z; Wang, J; Wang, L; Zhang, C; Zhang, K; Zhang, P; Zhao, H; Zhou, P; Zhu, HH | 1 |
| Ahmed, Z; Cook, NP; Gagea, M; Ladbury, JE; Lee, GR; Lin, CC; Marti, AA; Suen, KM; Timsah, Z | 1 |
| Bell, DG; Merrimen, J; Rendon, R; Thomas, LN; Too, CK | 1 |
| Bosland, MC; Chen, JX; Lee, MJ; Li, G; Liu, A; Reuhl, K; Suh, N; Wang, H; Yang, CS | 1 |
| Jiang, WG; Kynaston, HG; Sanders, AJ; Weeks, HP | 1 |
| Chung, LW; Gera, L; Iqbal, S; Johnson, NA; Qian, WP; Seo, SI; Stewart, J; Wang, R; Wu, D; Zayzafoon, M; Zhang, S; Zhau, HE | 1 |
| Duhagon Serrat, MA; Farrar, WL; Hurt, EM; Kawasaki, BT; Kim, HJ; Kim, JY; Klarmann, GJ; Qin, HR | 1 |
| Hikri, E; Nir, U; Shpungin, S | 1 |
| Gibbs, TC; Kipp, KR; Meier, KE; Rubio, MV; Xie, Y; Zhang, Z | 1 |
| Cárdenas-Rodríguez, N; Castro-Marín, M; Floriano-Sánchez, E | 1 |
| Bianchi, M; Boulay, A; Duss, S; Heinrich, C; Hofsteenge, J; Hynes, NE; Keller, C; Lienhard, S; Sack, R; Vecchi, M | 1 |
| Goel, HL; Hsieh, CC; Languino, LR; Nickerson, JA; Underwood, JM | 1 |
| Batra, SK; Chen, SJ; Chuang, TD; Kumar, S; Lin, FF; Lin, MF; Tu, Y; Veeramani, S | 1 |
| El Sayed, KA; Meyer, SA; Ramasahayam, S; Sallam, AA | 1 |
| Gray, JK; Hung, MC; Lo, YH; Ma, L; Waltz, SE; Wang, SC; Zhao, H | 1 |
| Cronauer, MV; Genze, F; Schrader, AJ; Schrader, M; Schütz, SV; Zengerling, F | 1 |
| Hong, SJ; Ju, J; Lee, J; Park, S; Yoon, S | 1 |
| Cai, H; Drake, JM; Goldstein, AS; Graeber, TG; Graham, NA; Huang, J; Komisopoulou, E; Sedghi, A; Smith, DA; Stoyanova, T; Witte, ON; Zhang, H | 1 |
| Chou, YW; Kumar, S; Lele, SM; Lin, FC; Lin, FF; Lin, MF; Muniyan, S; Tu, Y; Veeramani, S; Xie, Y | 1 |
| Allbritton, N; Lawrence, DS; Xu, W | 1 |
| Dalvi, P; Gokulgandhi, M; Kesh, S; Kohli, T; Mitra, AK; Pal, D; Patel, M | 1 |
| Daaka, Y; Harrington, LB; Kue, PF; Polakiewicz, RD; Taub, JS; Ullrich, A | 1 |
| Hsieh, JT; Scholes, J; Zhou, J | 1 |
| Di-Segni, A; Lupowitz, Z; Pinkas-Kramarski, R; Tal-Or, P | 1 |
| Angelucci, A; Bologna, M; Festuccia, C; Gravina, GL; Marronaro, A; Vicentini, C | 1 |
| Hu, Y; Stearns, ME; Wang, M | 2 |
| Fu, X; Fu, YM; Ge, X; Li, YQ; Meadows, GG; Sanchez, PJ; Yu, ZX | 1 |
| Davies, G; Jiang, WG; Lane, J; Martin, TA; Mason, MD; Matsumoto, K; Nakamura, T; Parr, C; Watkins, G | 1 |
| CAMERON, E; CAMPBELL, A | 1 |
| Holzbeierlein, J; Li, B; Liao, X; Stanley, S; Thrasher, JB | 1 |
| Igawa, T; Lee, MS; Lin, MF | 1 |
| Chang, NS; Hsu, LJ; Lewis, J; Schultz, L; Su, M; Sze, CI | 1 |
| Isoe, T; Kamishohara, M; Kubo, K; Miura, T; Nakamura, K; Shibuya, M; Taguchi, E; Takahashi, K; Yamamoto, A | 1 |
| Baldi, E; Bonaccorsi, L; Carloni, V; Forti, G; Marchiani, S; Muratori, M | 1 |
| Earp, HS; Fei, X; French, FS; Gregory, CW; Liu, Y; McCall, W; Ponguta, LA; Whang, YE; Wilson, EM | 1 |
| Battistini, L; Borsellino, G; Bronte, V; Gallana, K; Gri, G; Iafrate, M; Kasic, T; Marigo, I; Pagano, F; Prayer-Galetti, T; Viola, A | 1 |
| Liu, H; Meadows, GG; Núñez, NP | 1 |
| Fu, P; Gupta, S; MacLennan, GT; Mishra, A; Resnick, MI; Shukla, S | 1 |
| Earp, HS; Mahajan, NP; Mohler, JL; Whang, YE | 1 |
| Bulinski, JC; Eiserich, JP; Harper, RW; Kamaid, A; Kubala, L; Phung, AD; Soucek, K | 1 |
| Clark, DE; Jones, FE; Marrero, L; Vidal, GA | 1 |
| Amorino, GP; Deeble, PD; Parsons, SJ | 1 |
| Cedazo-Minguez, A; Chuan, YC; Flores-Morales, A; Norstedt, G; Pang, ST; Pousette, A | 1 |
| Bryant, I; Fry, R; Gallo, RM; Riese, DJ; Williams, EE | 1 |
| Beckonert, O; Cloarec, O; Holmes, E; Jackson, D; Mills, JD; Nicholson, JK; Nickson, J; Rantalainen, M; Rayner, S; Rowlinson, R; Tonge, R; Trygg, J; Wilkinson, RW; Wilson, ID | 1 |
| Brodie, AM; Chen, H; Dai, B; Guo, Z; Handratta, VD; Jiang, T; Kim, O; Kong, X; Melamed, J; Nesheiwat, I; Njar, VC; Qiu, Y; Veenstra, TD; Xie, Y; Xu, K; Yu, LR | 1 |
| Auricchio, F; Bottero, D; Castoria, G; Ciociola, A; De Falco, A; De Stasio, R; Di Domenico, M; Lombardi, M; Migliaccio, A; Nanayakkara, M; Varricchio, L | 1 |
| Anilkumar, G; Barwe, SP; Christiansen, JJ; Cooper, CR; Kohn, DB; Maul, RS; Rajasekaran, AK | 1 |
| Fang, P; Hwa, V; Little, BM; Rosenfeld, RG | 1 |
| Altshuler, D; Bell, DW; Daly, MB; Freedman, ML; Garber, JE; Godwin, AK; Haber, DA; Haiman, CA; Harris, PL; Haserlat, SM; Henderson, BE; Kim, SH; Le Marchand, L; Niendorf, KB; Olopade, OI; Schiripo, TA; Sgroi, DC; Smith, MR; Wahrer, DC | 1 |
| Appella, E; Auricchio, F; Castoria, G; de Falco, A; Di Domenico, M; Farrar, W; Giovannelli, P; Migliaccio, A; Varricchio, L; Yamaguchi, H | 1 |
| Araujo, JC; Gallick, GE; Gelovani, JG; Kim, SJ; Najjar, AM; Park, SI; Phillips, KA; Volgin, AY; Wang, Z; Zhang, J | 1 |
| Atfi, A; Boissonneault, M; Chapdelaine, A; Chevalier, S; Drobetsky, E | 1 |
| Bacus, SS; Chace, D; Chin, DM; Cohen, BD; Goetze, A; Green, JM; Hellström, I; Mixan, B; Plowman, GD; Siegall, CB | 1 |
| Dedhar, S; Jeevaratnam, P; Jewell, K; Kapron-Bras, C | 1 |
| DaVolio, J; Garcia, R; Lin, MF | 1 |
| Barnes, S; Peterson, G | 1 |
| Lin, MF; Meng, TC | 2 |
| Dondi, D; Limonta, P; Marelli, MM; Martini, L; Moretti, RM; Motta, M; Poletti, A | 1 |
| Aimola, P; Amicarelli, F; Arcadi, A; Bonfigli, A; Miranda, M; Natali, PG; Poma, A; Porretta, R; Ragnelli, AM; Savino, M; Zarivi, O | 1 |
| Grasso, AW; Kung, HJ; Miller, CM; Pretlow, TG; Rhim, JS; Wen, D | 1 |
| Hsu, CP; Mai, XY; Sheu, JC; Yang, CC; Yang, SD | 1 |
| Dondi, D; Limonta, P; Marelli, MM; Moretti, RM; Motta, M | 1 |
| Goretzki, L; Mueller, BM; Pfeifer, M; Yebra, M | 1 |
| Bingman, WE; Edwards, DP; James, AJ; Lamb, DJ; Mancini, M; Marcelli, M; Nazareth, LV; Stenoien, DL; Weigel, NL; Wu, C; Zhang, Y | 1 |
| Bielenberg, DR; Gagnon, ML; Gechtman, Z; Klagsbrun, M; Miao, HQ; Soker, S; Takashima, S | 1 |
| Burnstein, KL; Howard, GA; Ostenson, RC; Perez-Stable, CM; Qadan, LR; Roos, BA; Schwall, RH | 1 |
| Oberley, LW; Oberley, TD; Szweda, LI; Zhong, W | 1 |
| Campbell, CL; Jiang, Z; Savarese, DM; Savarese, TM | 1 |
| Davies, G; Jiang, WG; Mason, MD | 1 |
| Davies, G; Jiang, WG; Mason, MD; Matsumoto, K; Nakamura, T; Parr, C | 1 |
| Ge, X; Meadows, GG; Zhang, H | 1 |
| Dinney, CP; Fan, Z; Hicklin, DJ; Izawa, JI; Karashima, T; Kedar, D; Kim, SJ; Pettaway, C; Shuin, T; Slaton, JW; Sweeney, P | 1 |
| Aprikian, AG; Bégin, LR; Chevalier, S; Defoy, I; Guy, L; Hamel, L; Lacoste, J | 1 |
| Borner, MM; McLellan, CA; Myers, CE; Sartor, O | 1 |
| DaVolio, J; Garcia-Arenas, R; Lin, MF | 1 |
| Chapdelaine, A; Chevalier, S; Nguyen, L | 1 |
| Chu, TM; Lee, CL; Lee, H | 1 |
1 review(s) available for tyrosine and Cancer of Prostate
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
2 trial(s) available for tyrosine and Cancer of Prostate
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Humans; Kaplan-Meier Estimate; Male; Methoxsalen; Middle Aged; Neoplasm Recurrence, Local; Phenytoin; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Sirolimus; Tyrosine | 2021 |
95 other study(ies) available for tyrosine and Cancer of Prostate
| Article | Year |
|---|---|
Correlation between stage of prostate cancer and tyrosine and tryptophan in urine samples measured electrochemically.
Topics: Biomarkers, Tumor; Chromatography, Liquid; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Tryptophan; Tyrosine | 2022 |
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer.
Topics: Humans; Male; Phosphorylation; Prostatic Neoplasms; Tyrosine | 2022 |
TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability.
Topics: Adenosine Triphosphate; Animals; Autophagy; Humans; Male; Mice; Mice, Transgenic; Mitochondria; Phosphorylation; Prostatic Neoplasms; Protein-Tyrosine Kinases; Tyrosine | 2023 |
Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer patients.
Topics: China; Exome Sequencing; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Male; Prostatic Neoplasms; Protein Kinases; Tyrosine | 2022 |
Tyrosine-based asymmetric urea ligand for prostate carcinoma: Tuning biological efficacy through in silico studies.
Topics: Antigens, Surface; Computer Simulation; Glutamate Carboxypeptidase II; Humans; Ligands; Male; Microscopy, Confocal; Prostatic Neoplasms; Protein Binding; Tumor Cells, Cultured; Tyrosine; Urea | 2019 |
PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Edetic Acid; Glutamate Carboxypeptidase II; Humans; Kidney Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Tyrosine | 2020 |
Synthesis of a Unique Psammaplysin F Library and Functional Evaluation in Prostate Cancer Cells by Multiparametric Quantitative Single Cell Imaging.
Topics: Animals; Cell Line, Tumor; Humans; Male; Porifera; Prostatic Neoplasms; Single-Cell Analysis; Spectrum Analysis; Spiro Compounds; Tyrosine | 2020 |
The phospho-caveolin-1 scaffolding domain dampens force fluctuations in focal adhesions and promotes cancer cell migration.
Topics: Actinin; Actins; Caveolin 1; Cell Adhesion; Cell Movement; Cells, Cultured; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Humans; Male; Mutation; Phosphorylation; Prostatic Neoplasms; Protein Domains; src-Family Kinases; Talin; Tyrosine; Vinculin | 2017 |
Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasis.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Humans; Male; Mice, Nude; Neoplasm Metastasis; Phenylalanine; Prostatic Neoplasms; Reactive Oxygen Species; Serum; Signal Transduction; Subcutaneous Tissue; Tyrosine; Xenograft Model Antitumor Assays | 2018 |
CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Carcinoma; Chemokine CX3CL1; CX3C Chemokine Receptor 1; ErbB Receptors; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Male; Mice, Inbred NOD; Mice, SCID; Middle Aged; Neoplasm Invasiveness; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Signal Transduction; Spinal Neoplasms; src-Family Kinases; Tyrosine; Xenograft Model Antitumor Assays | 2018 |
Letter to the editor.
Topics: Humans; Isoleucine; Large Neutral Amino Acid-Transporter 1; Male; Prodrugs; Prostatic Neoplasms; Quinidine; Tyrosine | 2013 |
Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells [Int. J. Pharm. 443 (2013) 245-253].
Topics: Humans; Isoleucine; Large Neutral Amino Acid-Transporter 1; Male; Prodrugs; Prostatic Neoplasms; Quinidine; Tyrosine | 2013 |
Disruption of endothelial adherens junction by invasive breast cancer cells is mediated by reactive oxygen species and is attenuated by AHCC.
Topics: Acetylcysteine; Adherens Junctions; Antigens, CD; Antineoplastic Agents, Phytogenic; Antioxidants; beta Catenin; Breast Neoplasms; Cadherins; Cell Movement; Endothelial Cells; Endothelium, Vascular; Female; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Male; Ovarian Neoplasms; Plant Extracts; Prostatic Neoplasms; Reactive Oxygen Species; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tyrosine | 2013 |
C-Src-mediated phosphorylation of δ-catenin increases its protein stability and the ability of inducing nuclear distribution of β-catenin.
Topics: Animals; beta Catenin; Catenins; Cell Line, Tumor; CSK Tyrosine-Protein Kinase; Delta Catenin; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Male; Mice; Phosphorylation; Prostatic Neoplasms; Protein Stability; Proto-Oncogene Proteins c-akt; src-Family Kinases; Tyrosine | 2014 |
Synthesis and preliminary biological evaluation of O-2((2-[(18)F]fluoroethyl)methylamino)ethyltyrosine ([(18)F]FEMAET) as a potential cationic amino acid PET tracer for tumor imaging.
Topics: Amino Acid Transport Systems; Amino Acids; Animals; Blood-Brain Barrier; Cell Line, Tumor; Diagnostic Imaging; Female; Fluorine Radioisotopes; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasm Transplantation; Positron-Emission Tomography; Prostatic Neoplasms; Protein Transport; Radiopharmaceuticals; Small Cell Lung Carcinoma; Transplantation, Heterologous; Tyrosine | 2014 |
Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition.
Topics: Adaptor Proteins, Signal Transducing; Cell Cycle Proteins; Cell Polarity; Epithelial-Mesenchymal Transition; Humans; Male; Membrane Proteins; Neoplasm Metastasis; Neoplasm Staging; Phosphorylation; Prostatic Neoplasms; Protein Kinase C; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Survival Analysis; Tight Junctions; Tyrosine; Up-Regulation | 2016 |
Grb2 monomer-dimer equilibrium determines normal versus oncogenic function.
Topics: Breast Neoplasms; Colonic Neoplasms; Female; GRB2 Adaptor Protein; HEK293 Cells; Humans; Male; MAP Kinase Signaling System; Phosphorylation; Prostatic Neoplasms; Protein Multimerization; Signal Transduction; Son of Sevenless Proteins; src Homology Domains; Tissue Array Analysis; Tyrosine | 2015 |
Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
Topics: Carboxypeptidases; Humans; Ki-67 Antigen; Male; Neoplasm Grading; Nitric Oxide Synthase Type III; Phosphorylation; Prolactin; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Prolactin; Signal Transduction; STAT5 Transcription Factor; Testosterone; Tyrosine; Up-Regulation | 2015 |
Dietary tocopherols inhibit PhIP-induced prostate carcinogenesis in CYP1A-humanized mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anticarcinogenic Agents; Cyclooxygenase 2; Cytochrome P-450 CYP1A2; Deoxyguanosine; Diet; Disease Models, Animal; Humans; Imidazoles; Ki-67 Antigen; Male; Mice, Transgenic; NF-E2-Related Factor 2; Phosphorylation; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; Tocopherols; Tyrosine | 2016 |
The Association Between WAVE1 and -3 and the ARP2/3 Complex in PC 3 Cells.
Topics: Actin Cytoskeleton; Actin-Related Protein 2-3 Complex; Actins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Knockdown Techniques; Humans; Indoles; Male; Neoplasm Invasiveness; Phenotype; Phosphorylation; Polymerization; Prostatic Neoplasms; Protein Binding; RNA Interference; Signal Transduction; Thiophenes; Tyrosine; Wiskott-Aldrich Syndrome Protein Family | 2016 |
BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis.
Topics: Amides; Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Culture Media, Conditioned; Diphosphonates; Flow Cytometry; Humans; Male; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Prostatic Neoplasms; Tyrosine | 2008 |
Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation.
Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Male; Mice; Mice, Inbred NOD; Mice, SCID; Mutant Proteins; Phosphorylation; Point Mutation; Prostatic Neoplasms; Protein-Tyrosine Kinases; Serine; STAT3 Transcription Factor; Transplantation, Heterologous; Tyrosine | 2008 |
Hsp90 and a tyrosine embedded in the Hsp90 recognition loop are required for the Fer tyrosine kinase activity.
Topics: Adenocarcinoma; Amino Acid Motifs; Amino Acid Substitution; Animals; Binding Sites; Breast Neoplasms; Catalysis; Cell Line; Cell Line, Tumor; Epithelial Cells; Female; HSP90 Heat-Shock Proteins; Humans; Male; Mice; Mutagenesis, Site-Directed; Phosphorylation; Point Mutation; Prostatic Neoplasms; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Structure-Activity Relationship; Tyrosine | 2009 |
Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.
Topics: Cell Division; Cell Line, Tumor; Culture Media, Serum-Free; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Isomerism; Lysophospholipids; Male; Phosphorylation; Prostatic Neoplasms; Receptors, Lysophosphatidic Acid; Receptors, Lysosphingolipid; RNA, Messenger; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Tyrosine | 2009 |
[Molecular markers associated with prostate cancer: 3-nitrotyrosine and genetic and proteic expression of Mn-superoxide dismutasa (Mn-SOD)].
Topics: Gene Expression Regulation, Neoplastic; Genetic Markers; Humans; Male; Prostatic Neoplasms; Superoxide Dismutase; Tyrosine | 2009 |
Copine-III interacts with ErbB2 and promotes tumor cell migration.
Topics: Binding Sites; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Models, Biological; Ovarian Neoplasms; Phosphoproteins; Prostatic Neoplasms; Protein Binding; Receptor, ErbB-2; RNA Interference; Tyrosine | 2010 |
Beta1 integrins mediate cell proliferation in three-dimensional cultures by regulating expression of the sonic hedgehog effector protein, GLI1.
Topics: Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Humans; Insulin-Like Growth Factor I; Integrin alpha5; Integrin beta1; Male; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Recombinant Fusion Proteins; RNA Interference; Signal Transduction; Transcription Factors; Transfection; Tyrosine; Zinc Finger Protein GLI1 | 2010 |
Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth.
Topics: Acid Phosphatase; Animals; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Neoplasm Transplantation; Phosphorylation; Prostatic Neoplasms; Protein Tyrosine Phosphatases; Receptor, ErbB-2; Subcellular Fractions; Tyrosine | 2010 |
Design, synthesis, and biological evaluation of dibromotyrosine analogues inspired by marine natural products as inhibitors of human prostate cancer proliferation, invasion, and migration.
Topics: Angiogenesis Inhibitors; Animals; Binding Sites; Biological Products; Cell Line, Tumor; Cell Movement; Cell Proliferation; Computer Simulation; Drug Design; Humans; Male; Neovascularization, Pathologic; Porifera; Prostatic Neoplasms; Tyrosine; Vascular Endothelial Growth Factor Receptor-2 | 2010 |
Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth.
Topics: Amino Acid Sequence; Animals; Cell Growth Processes; Cell Line, Tumor; Cell Survival; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Molecular Sequence Data; Molecular Targeted Therapy; Peptides; Phosphorylation; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Tyrosine; Xenograft Model Antitumor Assays | 2011 |
Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer.
Topics: Active Transport, Cell Nucleus; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Enzyme Activation; Exportin 1 Protein; Gene Silencing; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Karyopherins; Ligands; Male; Maleimides; Orchiectomy; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Receptors, Androgen; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Tyrosine; Up-Regulation | 2011 |
Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of β-catenin signaling in hormone refractory PC-3 prostate cancer cells.
Topics: beta Catenin; Cadherins; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Genistein; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Insulin-Like Growth Factor I; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins pp60(c-src); Receptor, IGF Type 1; Signal Transduction; Tyrosine | 2012 |
Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression.
Topics: Animals; Enzyme Activation; Male; Mass Spectrometry; Mice; Oncogenes; Phosphorylation; Prostatic Neoplasms; Protein-Tyrosine Kinases; Proteomics; Tyrosine; Up-Regulation | 2012 |
Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells.
Topics: Androgens; Animals; Blotting, Western; Cell Proliferation; Humans; Hydrogen Peroxide; Immunoenzyme Techniques; Immunoprecipitation; Longevity; Male; Mice; Oxidants; Oxidation-Reduction; Phosphorylation; Prostatic Neoplasms; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Reactive Oxygen Species; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Tumor Cells, Cultured; Tyrosine; Xenograft Model Antitumor Assays | 2012 |
SRC kinase regulation in progressively invasive cancer.
Topics: Cell Line, Tumor; Humans; Kinetics; Male; Neoplasm Invasiveness; Phosphorylation; Prostatic Neoplasms; Signal Transduction; src-Family Kinases; Tyrosine | 2012 |
Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells.
Topics: Biological Transport; Cell Culture Techniques; Cell Line, Tumor; Chromatography, Liquid; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Isoleucine; Large Neutral Amino Acid-Transporter 1; Male; Prodrugs; Prostatic Neoplasms; Quinidine; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity; Tandem Mass Spectrometry; Temperature; Time Factors; Tyrosine | 2013 |
Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells.
Topics: Androgens; Enzyme Activation; ErbB Receptors; Humans; Lysophospholipids; Male; MAP Kinase Signaling System; Matrix Metalloproteinases; Neoplasms, Hormone-Dependent; Phosphorylation; Prostatic Neoplasms; Transcriptional Activation; Tumor Cells, Cultured; Tyrosine | 2002 |
Characterization of a novel negative regulator (DOC-2/DAB2) of c-Src in normal prostatic epithelium and cancer.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Animals; Apoptosis Regulatory Proteins; COS Cells; CSK Tyrosine-Protein Kinase; Enzyme Activation; Enzyme Inhibitors; Genes, Tumor Suppressor; Glutathione Transferase; Humans; Male; Mitogen-Activated Protein Kinases; Models, Biological; Mutation; Peptides; Phosphorylation; Precipitin Tests; Prostate; Prostatic Neoplasms; Protein Binding; Protein Biosynthesis; Protein Conformation; Protein Kinase C; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Signal Transduction; src-Family Kinases; Time Factors; Transfection; Tumor Cells, Cultured; Tumor Suppressor Proteins; Tyrosine | 2003 |
Neuregulin promotes autophagic cell death of prostate cancer cells.
Topics: Adenine; Amino Acid Chloromethyl Ketones; Autophagy; Cell Death; Cell Division; Chromones; Cysteine Proteinase Inhibitors; Enzyme Inhibitors; Epidermal Growth Factor; Humans; Ligands; Male; Morpholines; Neuregulins; Phosphorylation; Prostatic Neoplasms; Tumor Cells, Cultured; Tyrosine | 2003 |
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Division; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Gefitinib; Humans; In Vitro Techniques; Male; Phosphorylation; Prostatic Neoplasms; Protein-Tyrosine Kinases; Quinazolines; Tumor Cells, Cultured; Tyrosine | 2003 |
A novel IL-10 signalling mechanism regulates TIMP-1 expression in human prostate tumour cells.
Topics: Amino Acid Sequence; Gene Expression Regulation, Neoplastic; Humans; Interleukin-10; Male; Molecular Sequence Data; Phosphorylation; Prostatic Neoplasms; Protease Inhibitors; Receptors, Interleukin; Receptors, Interleukin-10; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Tumor Cells, Cultured; Tyrosine | 2003 |
Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells.
Topics: Amino Acids; Androgens; Animals; Apoptosis; Cell Adhesion; Cell Cycle; Cell Division; Cell Line, Tumor; DNA Fragmentation; Flow Cytometry; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Male; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Phenylalanine; Phosphorylation; Prostatic Neoplasms; Protein-Tyrosine Kinases; Tyrosine | 2003 |
IL-10 signaling via IL-10E1 is dependent on tyrosine phosphorylation in the IL-10R alpha chain in human primary prostate cancer cell lines.
Topics: Active Transport, Cell Nucleus; Amino Acid Sequence; Enhancer Elements, Genetic; Humans; Interleukin-10; Interleukin-4; Male; Microscopy, Confocal; Molecular Sequence Data; Phosphorylation; Prostatic Neoplasms; Receptors, Interleukin; Receptors, Interleukin-10; STAT6 Transcription Factor; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; Tyrosine | 2003 |
The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.
Topics: Animals; beta-Lactamases; Blotting, Western; Cell Adhesion; Cell Division; Cell Movement; Female; Fibroblasts; Hepatocyte Growth Factor; Humans; Male; Mice; Mice, Nude; Mitogens; Neoplasm Invasiveness; Neovascularization, Pathologic; Phosphoproteins; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-met; Survival Rate; Tumor Cells, Cultured; Tyrosine | 2003 |
THE VALUE OF SEROMUCOID ESTIMATION IN THE MANAGEMENT OF PROSTATIC DISEASE.
Topics: Acid Phosphatase; Blood Chemical Analysis; Diagnosis, Differential; Humans; Male; Mucoproteins; Neoplasms; Orosomucoid; Prostatectomy; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Tyrosine | 1964 |
Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Topics: Androgens; beta Catenin; Biological Transport; Cell Line, Tumor; Cell Nucleus; Cytoskeletal Proteins; Enzyme Inhibitors; Gene Expression Regulation; Gene Silencing; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Male; Phosphorylation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Androgen; RNA, Small Interfering; Trans-Activators; Tyrosine | 2004 |
Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Androgens; Cell Division; Cell Line, Tumor; Humans; Male; Prostatic Neoplasms; Receptor, ErbB-2; Recombinant Proteins; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Transfection; Tyrosine | 2004 |
17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.
Topics: Animals; Breast Neoplasms; Cell Line; Chlorocebus aethiops; Disease Progression; Estradiol; Humans; Hyperplasia; Male; Mice; Mitochondria; Neoplasm Metastasis; Oxidoreductases; Phosphorylation; Prostatic Neoplasms; Protein Binding; Protein Transport; Receptors, Androgen; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Tyrosine; Up-Regulation; WW Domain-Containing Oxidoreductase | 2005 |
KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth.
Topics: Angiogenesis Inhibitors; Animals; Cell Proliferation; Colonic Neoplasms; Endothelial Cells; Enzyme Activation; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Phosphorylation; Prostatic Neoplasms; Quinazolines; Rats; Rats, Nude; Transplantation, Heterologous; Tyrosine; Umbilical Veins; Vascular Endothelial Growth Factor Receptor-2 | 2004 |
Signaling mechanisms that mediate invasion in prostate cancer cells.
Topics: Androgens; Cell Line, Tumor; Cell Proliferation; Collagen; Drug Combinations; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Immunoprecipitation; Laminin; Male; Neoplasm Invasiveness; Phenotype; Phosphatidylinositol 3-Kinases; Phosphorylation; Prostatic Neoplasms; Proteoglycans; Quinazolines; Receptors, Androgen; Signal Transduction; Transfection; Tyrosine | 2004 |
Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth.
Topics: Genes, erbB-2; Genes, Reporter; Humans; Male; Neuregulin-1; Phosphorylation; Prostatic Neoplasms; Receptor, ErbB-2; Receptor, ErbB-3; Receptors, Androgen; Recurrence; Signal Transduction; Transcriptional Activation; Tumor Cells, Cultured; Tyrosine | 2005 |
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.
Topics: Adenocarcinoma; Animals; Arginase; Arginine; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Humans; Interferon-gamma; Lymphocyte Count; Lymphocytes, Tumor-Infiltrating; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide Synthase; Organ Culture Techniques; Prostatic Neoplasms; T-Lymphocyte Subsets; Tyrosine | 2005 |
PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells.
Topics: Amino Acids; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Hypoglycemic Agents; Immunologic Factors; Ligands; Male; Melanoma; Methionine; Phenylalanine; PPAR gamma; Prostaglandin D2; Prostatic Neoplasms; Thiazolidinediones; Tyrosine | 2006 |
Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice.
Topics: Adaptor Proteins, Signal Transducing; Administration, Oral; Animals; Antineoplastic Agents; Apigenin; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Culture Media; Dose-Response Relationship, Drug; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Male; Methylcellulose; Mice; Mice, Nude; Models, Biological; Neoplasm Transplantation; Oligonucleotides, Antisense; Phosphorylation; Polysorbates; Prostatic Neoplasms; Receptor, IGF Type 1; RNA, Messenger; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Time Factors; Tyrosine; Up-Regulation | 2005 |
Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.
Topics: Amino Acid Sequence; Animals; c-Mer Tyrosine Kinase; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Cell Transformation, Neoplastic; Enzyme Activation; HSP90 Heat-Shock Proteins; Humans; Male; Mice; Mice, Nude; Molecular Sequence Data; Oxidoreductases; Phosphorylation; Prostatic Neoplasms; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Tumor Suppressor Proteins; Tyrosine; Ubiquitin; WW Domain-Containing Oxidoreductase | 2005 |
Normal and prostate cancer cells display distinct molecular profiles of alpha-tubulin posttranslational modifications.
Topics: Acetylation; Androgens; Blotting, Western; Cell Line; Cell Line, Tumor; Disease Progression; Electrophoresis, Polyacrylamide Gel; Epithelium; Humans; Male; Microscopy, Fluorescence; Peptide Synthases; Polyglutamic Acid; Prostate; Prostatic Neoplasms; Protein Processing, Post-Translational; Receptors, Androgen; Tubulin; Tyrosine | 2006 |
A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities.
Topics: Alleles; Apoptosis; Breast Neoplasms; Caseins; Cell Nucleus; Cells, Cultured; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Kidney; Male; Ovarian Neoplasms; Phosphorylation; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Transport; Receptor, ErbB-4; STAT5 Transcription Factor; Transcription, Genetic; Transcriptional Activation; Tumor Suppressor Proteins; Tyrosine | 2007 |
Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.
Topics: Cell Differentiation; Cell Proliferation; Culture Media, Conditioned; DNA, Neoplasm; ErbB Receptors; Humans; Male; Matrix Metalloproteinases; Neurosecretory Systems; Neurotensin; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins pp60(c-src); Signal Transduction; STAT5 Transcription Factor; Trans-Activators; Transcription, Genetic; Tumor Cells, Cultured; Tyrosine | 2007 |
Androgen induction of prostate cancer cell invasion is mediated by ezrin.
Topics: Amino Acid Substitution; Androgens; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Collagen; Cytoskeletal Proteins; Drug Combinations; Humans; Laminin; Male; Neoplasm Invasiveness; Phosphorylation; Prostatic Neoplasms; Proteoglycans; Threonine; Tyrosine | 2006 |
Phosphorylation of ErbB4 on Tyr1056 is critical for inhibition of colony formation by prostate tumor cell lines.
Topics: Alternative Splicing; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glutamic Acid; Humans; Male; Phosphorylation; Prostatic Neoplasms; Receptor, ErbB-4; Signal Transduction; Tyrosine | 2006 |
Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice.
Topics: Animals; Biomarkers, Tumor; Blood Proteins; Cell Line, Tumor; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Gelsolin; Humans; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C57BL; Prostatic Neoplasms; Proteomics; Transplantation, Heterologous; Tyrosine | 2006 |
Regulation of androgen receptor activity by tyrosine phosphorylation.
Topics: Androgens; Animals; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Dihydrotestosterone; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Indoles; Interleukin-6; Kinetics; Male; Mice; Mice, SCID; Neuregulin-1; Phosphorylation; Prostatic Neoplasms; Pyrimidines; Receptors, Androgen; src-Family Kinases; Sulfonamides; Tyrosine; Xenograft Model Antitumor Assays | 2006 |
Crosstalk between EGFR and extranuclear steroid receptors.
Topics: Androgen Receptor Antagonists; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Male; Phosphorylation; Prostatic Neoplasms; Receptor Cross-Talk; Receptors, Androgen; Receptors, Steroid; Signal Transduction; src-Family Kinases; Tyrosine; Up-Regulation | 2006 |
Preferential association of prostate cancer cells expressing prostate specific membrane antigen to bone marrow matrix.
Topics: Actins; Antigens, Surface; Bone Marrow; Bone Matrix; Bone Neoplasms; Cell Adhesion; Cell Movement; Focal Adhesion Kinase 1; Glutamate Carboxypeptidase II; Humans; Male; Phosphorylation; Prostatic Neoplasms; Pseudopodia; Tumor Cells, Cultured; Tyrosine | 2007 |
IGFBP-3 sensitizes prostate cancer cells to interferon-gamma-induced apoptosis.
Topics: Animals; Apoptosis; Cell Proliferation; Insulin-Like Growth Factor Binding Protein 3; Interferon-gamma; Male; Phosphorylation; Prostatic Neoplasms; Protein Kinases; Recombinant Proteins; Signal Transduction; STAT1 Transcription Factor; TOR Serine-Threonine Kinases; Transfection; Tyrosine | 2008 |
Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts.
Topics: Adult; Age of Onset; Aged; Asian People; Black or African American; Breast Neoplasms; Case-Control Studies; Checkpoint Kinase 2; DNA Mutational Analysis; DNA, Complementary; Female; Gene Frequency; Genetic Predisposition to Disease; Germ-Line Mutation; Hawaii; Hispanic or Latino; Histidine; Humans; Isoleucine; Leucine; Male; Middle Aged; Mutation; Mutation, Missense; Predictive Value of Tests; Proline; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Risk Assessment; Risk Factors; Threonine; Tyrosine; United States; White People | 2007 |
Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor alpha tyrosine-phosphorylated peptide.
Topics: Amino Acid Sequence; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor alpha; Female; Humans; Male; Mice; Molecular Sequence Data; Oligopeptides; Phosphorylation; Prostatic Neoplasms; src-Family Kinases; Tyrosine; Xenograft Model Antitumor Assays | 2007 |
Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model.
Topics: Animals; Antineoplastic Agents; Cell Movement; Cell Proliferation; Crk-Associated Substrate Protein; Dasatinib; Disease Models, Animal; Drug Delivery Systems; Focal Adhesion Kinase 1; Humans; Lymphatic Metastasis; Male; Mice; Mice, Nude; Prostatic Neoplasms; Pyrimidines; src-Family Kinases; Thiazoles; Tumor Burden; Tumor Cells, Cultured; Tyrosine; Xenograft Model Antitumor Assays | 2008 |
Transforming growth factor beta down-regulates Src family protein tyrosine kinase signaling pathways.
Topics: Blotting, Western; Cell Line; Humans; Male; Oncogene Protein pp60(v-src); Oncogene Proteins, Viral; Phosphoproteins; Phosphotyrosine; Prostatic Neoplasms; Protein-Tyrosine Kinases; Receptors, Transforming Growth Factor beta; Signal Transduction; src-Family Kinases; Transforming Growth Factor beta; Tumor Cells, Cultured; Tyrosine; Vanadates | 1994 |
HER4 expression correlates with cytotoxicity directed by a heregulin-toxin fusion protein.
Topics: ADP Ribose Transferases; Amino Acid Sequence; Animals; Bacterial Toxins; Base Sequence; Breast Neoplasms; Cell Line; Cell Survival; DNA Primers; ErbB Receptors; Exotoxins; Female; Gene Expression; Glycoproteins; Humans; Immunotoxins; Kidney; Kinetics; Leukemia, T-Cell; Lung Neoplasms; Male; Molecular Sequence Data; Neuregulins; Ovarian Neoplasms; Phosphorylation; Phosphotyrosine; Polymerase Chain Reaction; Prostatic Neoplasms; Pseudomonas aeruginosa; Pseudomonas aeruginosa Exotoxin A; Rats; Receptor, ErbB-4; Recombinant Fusion Proteins; RNA, Messenger; Tumor Cells, Cultured; Tyrosine; Virulence Factors | 1995 |
Stimulation of tyrosine phosphorylation of distinct proteins in response to antibody-mediated ligation and clustering of alpha 3 and alpha 6 integrins.
Topics: Antibodies; Antigens, Surface; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Cross-Linking Reagents; Endothelium, Vascular; Fluorescent Antibody Technique; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Integrin alpha3beta1; Integrin alpha6beta1; Integrin alpha6beta4; Integrins; Male; Phosphorylation; Prostatic Neoplasms; Protein-Tyrosine Kinases; Proteins; Signal Transduction; Tumor Cells, Cultured; Tyrosine | 1995 |
Cationic liposome-mediated incorporation of prostatic acid phosphatase protein into human prostate carcinoma cells.
Topics: Acid Phosphatase; Cations; Fluorescent Antibody Technique; Humans; Male; Phosphatidylethanolamines; Phosphotyrosine; Prostatic Neoplasms; Time Factors; Transfection; Tumor Cells, Cultured; Tyrosine | 1993 |
Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation.
Topics: Anticarcinogenic Agents; Catechols; Cell Division; Epidermal Growth Factor; ErbB Receptors; Estrogens, Non-Steroidal; Genistein; Humans; Isoflavones; Male; Nitriles; Phosphorylation; Prostatic Neoplasms; Protein-Tyrosine Kinases; Tumor Cells, Cultured; Tyrosine; Tyrphostins | 1993 |
Tyrosine phosphorylation of a 185 kDa phosphoprotein (pp185) inversely correlates with the cellular activity of human prostatic acid phosphatase.
Topics: Acid Phosphatase; Humans; Male; Phosphorylation; Prostatic Neoplasms; Tartrates; Tumor Cells, Cultured; Tyrosine | 1996 |
Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145.
Topics: Cell Division; Epidermal Growth Factor; ErbB Receptors; Gene Expression; Genes, fos; Gonadotropin-Releasing Hormone; Humans; Male; Phosphorylation; Prostatic Neoplasms; Tumor Cells, Cultured; Tyrosine | 1996 |
Molecular approach to the nucleo-melanosomal interaction in human melanoma cells.
Topics: Animals; Cell Nucleus; DNA Topoisomerases, Type I; DNA-Binding Proteins; DNA, Neoplasm; DNA, Superhelical; Electrophoresis; Enzyme Inhibitors; Fibroblasts; Humans; Indoles; Liposomes; Male; Melanoma; Monophenol Monooxygenase; Nucleic Acid Denaturation; Oxidation-Reduction; Plasmids; Prostatic Neoplasms; Rabbits; Tritium; Tumor Cells, Cultured; Tyrosine | 1997 |
ErbB kinases and NDF signaling in human prostate cancer cells.
Topics: Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma; Cell Division; DNA-Binding Proteins; Enzyme Activation; ErbB Receptors; Glycoproteins; Humans; Isoenzymes; Male; Milk Proteins; Mitogen-Activated Protein Kinases; Neuregulins; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phospholipase C gamma; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins; Receptor, ErbB-2; Receptor, ErbB-3; Recombinant Proteins; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Trans-Activators; Transforming Growth Factor alpha; Transplantation, Heterologous; Tumor Cells, Cultured; Type C Phospholipases; Tyrosine | 1997 |
Differential tyrosine phosphorylation/activation of oncogenic proline-directed protein kinase F(A)/GSK-3alpha in well and poorly differentiated human prostate carcinoma cells.
Topics: Amino Acid Sequence; Calcium-Calmodulin-Dependent Protein Kinases; Cell Differentiation; Enzyme Activation; Enzyme Inhibitors; Genistein; Glycogen Synthase Kinase 3; Humans; Male; Molecular Sequence Data; Oncogenes; Phosphorylation; Prostatic Neoplasms; Tumor Cells, Cultured; Tyrosine; Vanadates | 1998 |
Tyrosine phosphorylation of c-ErbB-2 is regulated by the cellular form of prostatic acid phosphatase in human prostate cancer cells.
Topics: Acid Phosphatase; Humans; Male; Molecular Weight; Phosphorylation; Prostate; Prostatic Neoplasms; Receptor, ErbB-2; Tartrates; Tumor Cells, Cultured; Tyrosine | 1998 |
Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells.
Topics: Blotting, Western; Cell Division; Gonadotropin-Releasing Hormone; Goserelin; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Male; Prostatic Neoplasms; Somatomedins; Tumor Cells, Cultured; Tyrosine | 1999 |
Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
Topics: Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Crk-Associated Substrate Protein; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Male; Phosphoproteins; Phosphorylation; Prostatic Neoplasms; Protein-Tyrosine Kinases; Proteins; Receptors, Cell Surface; Receptors, Fibronectin; Receptors, Urokinase Plasminogen Activator; Retinoblastoma-Like Protein p130; Signal Transduction; Transfection; Tumor Cells, Cultured; Tyrosine; Urokinase-Type Plasminogen Activator | 1999 |
A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1)
Topics: Cell Nucleus; Chromosome Mapping; Cysteine; Cytoplasm; DNA; HeLa Cells; Histone Acetyltransferases; Humans; Male; Middle Aged; Mutation; Nuclear Receptor Coactivator 1; Prostatic Neoplasms; Receptors, Androgen; Response Elements; Transcription Factors; Transfection; Tyrosine; X Chromosome | 1999 |
Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Northern; CHO Cells; Cloning, Molecular; Cricetinae; DNA, Complementary; Endothelial Growth Factors; Humans; Introns; Liver; Lymphokines; Male; Molecular Sequence Data; Neoplasm Transplantation; Nerve Tissue Proteins; Neuropilin-1; Phosphorylation; Prostatic Neoplasms; Protein Binding; Protein Isoforms; Rats; Recombinant Proteins; Tissue Distribution; Tumor Cells, Cultured; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Hepatocyte growth factor and vitamin D cooperatively inhibit androgen-unresponsive prostate cancer cell lines.
Topics: Androgens; Cell Cycle; Cell Division; Drug Resistance; Drug Synergism; Hepatocyte Growth Factor; Humans; Male; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-met; RNA, Messenger; Tumor Cells, Cultured; Tyrosine; Vitamin D | 2000 |
Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenocarcinoma; Antibodies, Monoclonal; Antioxidants; Bone Neoplasms; Catalase; Deoxyguanosine; Glutathione Peroxidase; Humans; Immunoenzyme Techniques; Lipofuscin; Male; Prostate; Prostatic Neoplasms; Reactive Oxygen Species; Superoxide Dismutase; Tyrosine | 2000 |
Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.
Topics: Adenocarcinoma; Blotting, Western; Cell Line; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Hyperplasia; Immunohistochemistry; Interleukin-11; Interleukin-11 Receptor alpha Subunit; Male; Phosphorylation; Prostate; Prostatic Neoplasms; Receptors, Interleukin; Receptors, Interleukin-11; RNA, Messenger; STAT3 Transcription Factor; Trans-Activators; Tumor Cells, Cultured; Tyrosine | 2001 |
HGF/SF modifies the interaction between its receptor c-Met, and the E-cadherin/catenin complex in prostate cancer cells.
Topics: beta Catenin; Cadherins; Cytoskeletal Proteins; Hepatocyte Growth Factor; Humans; Macromolecular Substances; Male; Phosphorylation; Precipitin Tests; Prostatic Neoplasms; Protein Binding; Proto-Oncogene Proteins c-met; Trans-Activators; Tumor Cells, Cultured; Tyrosine | 2001 |
The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant.
Topics: Antineoplastic Agents; Blotting, Western; Cell Adhesion; Cell Division; Cell Movement; Cytoskeletal Proteins; Extracellular Matrix; Fluorescent Antibody Technique; Hepatocyte Growth Factor; Humans; Male; Mitogens; Neoplasm Invasiveness; Paxillin; Phosphoproteins; Phosphorylation; Prostatic Neoplasms; Tumor Cells, Cultured; Tyrosine | 2001 |
Specific amino acid deficiency alters the expression of genes in human melanoma and other tumor cell lines.
Topics: Blotting, Western; Breast Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Melanoma; Mitogen-Activated Protein Kinase Kinases; Phenylalanine; Phosphorylation; Prostatic Neoplasms; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Tyrosine | 2001 |
Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice.
Topics: Androgens; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; Blood Vessels; Cell Cycle Proteins; Cell Division; Cetuximab; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Epidermal Growth Factor; ErbB Receptors; Humans; Interleukin-8; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Paclitaxel; Phosphorylation; Prostatic Neoplasms; RNA, Messenger; Tumor Cells, Cultured; Tumor Suppressor Proteins; Tyrosine; Up-Regulation; Xenograft Model Antitumor Assays | 2002 |
Vascular endothelial growth factor and signaling in the prostate: more than angiogenesis.
Topics: Amino Acid Sequence; Animals; Carcinoma; Culture Media, Serum-Free; Dogs; Endothelial Growth Factors; Epithelial Cells; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Intercellular Signaling Peptides and Proteins; Lymph Nodes; Lymphokines; Male; Molecular Sequence Data; Neovascularization, Physiologic; Neurosecretory Systems; Phosphorylation; Placenta; Pregnancy; Prostate; Prostatic Neoplasms; Protein Binding; Protein-Tyrosine Kinases; Receptors, Growth Factor; Signal Transduction; Tumor Cells, Cultured; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors | 2002 |
Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines.
Topics: 3T3 Cells; Animals; Dose-Response Relationship, Drug; Humans; Male; Mice; Molecular Weight; Neoplasm Proteins; Peptide Mapping; Phosphoproteins; Phosphorylation; Phosphotyrosine; Prostatic Neoplasms; Suramin; Time Factors; Tumor Cells, Cultured; Tyrosine | 1992 |
Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells.
Topics: Acid Phosphatase; Base Sequence; Carcinoma; Cell Division; Dihydrotestosterone; DNA; Gene Expression; Humans; In Vitro Techniques; Male; Molecular Sequence Data; Oligodeoxyribonucleotides; Phosphotyrosine; Prostatic Neoplasms; RNA, Messenger; Transfection; Tumor Cells, Cultured; Tyrosine | 1992 |
Prostatic acid phosphatase in serum of patients with prostatic cancer is a specific phosphotyrosine acid phosphatase.
Topics: Acid Phosphatase; Alkaline Phosphatase; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Phosphoprotein Phosphatases; Phosphotyrosine; Prostatic Neoplasms; Protein Tyrosine Phosphatases; Reproducibility of Results; Semen; Tyrosine | 1990 |
Endogenous protein substrates for prostatic acid phosphatase in human prostate.
Topics: Acid Phosphatase; Humans; Hydrogen-Ion Concentration; Hydrolysis; Male; Phosphoprotein Phosphatases; Phosphoproteins; Phosphorylation; Phosphotyrosine; Prostate; Prostatic Neoplasms; Substrate Specificity; Tumor Cells, Cultured; Tyrosine | 1991 |